ID: ALA3968442

Max Phase: Preclinical

Molecular Formula: C15H9BrN2O2

Molecular Weight: 329.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1ccc2c3n(c(=O)c(=O)cc1-3)c1ccc(Br)cc21

Standard InChI:  InChI=1S/C15H9BrN2O2/c1-17-5-4-9-10-6-8(16)2-3-11(10)18-14(9)12(17)7-13(19)15(18)20/h2-7H,1H3

Standard InChI Key:  OXSNYKNYWGEOGI-UHFFFAOYSA-N

Associated Targets(non-human)

Meriones unguiculatus 417 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 329.15Molecular Weight (Monoisotopic): 327.9847AlogP: 2.46#Rotatable Bonds: 0
Polar Surface Area: 43.48Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.23CX LogD: 2.23
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.47Np Likeness Score: -0.20

References

1. Sasaki T, Li W, Ohmoto T, Koike K..  (2016)  Evaluation of canthinone alkaloids as cerebral protective agents.,  26  (20): [PMID:27623547] [10.1016/j.bmcl.2016.09.006]

Source